Literature DB >> 29178458

Impairment of Bone Remodeling in LIGHT/TNFSF14-Deficient Mice.

Giacomina Brunetti1, Maria Felicia Faienza2, Graziana Colaianni3, Isabella Gigante1, Angela Oranger1, Paolo Pignataro1, Giuseppe Ingravallo4, Adriana Di Benedetto5, Sara Bortolotti1, Mariasevera Di Comite1, Giuseppina Storlino1, Luciana Lippo1, Lindsay Ward-Kavanagh6, Giorgio Mori5, Janne E Reseland7, Giovanni Passeri8, Ernestina Schipani9, Koji Tamada10, Carl F Ware6, Silvia Colucci1, Maria Grano3.   

Abstract

Multiple cytokines produced by immune cells induce remodeling and aid in maintaining bone homeostasis through differentiation of bone-forming osteoblasts and bone-resorbing osteoclasts. Here, we investigate bone remodeling controlled by the tumor necrosis factor (TNF) superfamily cytokine LIGHT. LIGHT-deficient mice (Tnfsf14-/- ) exhibit spine deformity and reduced femoral cancellous bone mass associated with an increase in the osteoclast number and a slight decrease of osteoblasts compared with WT mice. The effect of LIGHT in bone cells can be direct or indirect, mediated by both the low expression of the anti-osteoclastogenic osteoprotegerin (OPG) in B and T cells and reduced levels of the pro-osteoblastogenic Wnt10b in CD8+ T cells in Tnfsf14-/- mice. LIGHT stimulation increases OPG levels in B, CD8+ T, and osteoblastic cells, as well as Wnt10b expression in CD8+ T cells. The high bone mass in Light and T- and B-cell-deficient mice (Rag- /Tnfsf14- ) supports the cooperative role of the immune system in bone homeostasis. These results implicate LIGHT as a potential target in bone disease.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Keywords:  GENETIC ANIMAL MODELS; OSTEOBLASTS; OSTEOCLASTS; OSTEOIMMUNOLOGY

Mesh:

Substances:

Year:  2017        PMID: 29178458     DOI: 10.1002/jbmr.3345

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

1.  An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases.

Authors:  Giacomina Brunetti; Gabriele D'Amato; Mariangela Chiarito; Apollonia Tullo; Graziana Colaianni; Silvia Colucci; Maria Grano; Maria Felicia Faienza
Journal:  World J Pediatr       Date:  2018-10-20       Impact factor: 2.764

2.  Shedding "LIGHT" on the Link between Bone and Fat in Obese Children and Adolescents.

Authors:  Giacomina Brunetti; Maria Felicia Faienza; Laura Piacente; Giuseppina Storlino; Angela Oranger; Gabriele D'Amato; Gianpaolo De Filippo; Silvia Colucci; Maria Grano
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

3.  LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens.

Authors:  Giacomina Brunetti; Rita Rizzi; Giuseppina Storlino; Sara Bortolotti; Graziana Colaianni; Lorenzo Sanesi; Luciana Lippo; Maria Felicia Faienza; Anna Mestice; Paola Curci; Giorgina Specchia; Maria Grano; Silvia Colucci
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

4.  Editorial: Special Issue on "Molecular Mechanisms Regulating Osteoclastogenesis".

Authors:  Giacomina Brunetti; Giorgio Mori; Maria Felicia Faienza
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

Review 5.  Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System.

Authors:  Marco Ponzetti; Nadia Rucci
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-18       Impact factor: 5.555

6.  MicroRNA-29a Counteracts Glucocorticoid Induction of Bone Loss through Repressing TNFSF13b Modulation of Osteoclastogenesis.

Authors:  Re-Wen Wu; Wei-Shiung Lian; Yu-Shan Chen; Chung-Wen Kuo; Huei-Ching Ke; Chin-Kuei Hsieh; Shao-Yu Wang; Jih-Yang Ko; Feng-Sheng Wang
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.